Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000572581 | SCV000674141 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000632662 | SCV000753848 | likely benign | Neurofibromatosis, type 2 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726250 | SCV001962433 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | NF2: BP4, BP7 |
KCCC/NGS Laboratory, |
RCV000632662 | SCV004016463 | likely benign | Neurofibromatosis, type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003320476 | SCV004024676 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing |